Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double-blind, placebo-controlled phase III study in Asian patients

Binding Characteristics and Analgesic Effects of Mirogabalin, a Novel Ligand for theα2δSubunit of Voltage-Gated Calcium Channels

(2018) Yuki Domon et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Identification, prevalence, and treatment of painful diabetic neuropathy in patients from a rural area in South Carolina

(2017) Jimmy Pruitt III et al.   Journal of Pain Research

Healthcare utilization and costs in diabetes relative to the clinical spectrum of painful diabetic peripheral neuropathy

(2015) Alesia Sadosky et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis

(2015) Nanna B Finnerup et al.   LANCET NEUROLOGY

Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States

(2015) Mei Yang et al.   PAIN MEDICINE

Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

(2014) Aaron Vinik et al.   DIABETES CARE

Burden of Illness Associated with Peripheral and Central Neuropathic Pain among Adults Seeking Treatment in the United States: A Patient-Centered Evaluation

(2014) Caroline Schaefer et al.   PAIN MEDICINE

Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey

(2013) Alesia Sadosky et al.   Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Randomized, Placebo-Controlled Comparison of Amitriptyline, Duloxetine, and Pregabalin in Patients With Chronic Diabetic Peripheral Neuropathic Pain: Impact on pain, polysomnographic sleep, daytime functioning, and quality of life

(2012) J. Boyle et al.   DIABETES CARE

Pregabalin Treatment for Peripheral Neuropathic Pain

(2012) Setsuro Ogawa et al.   DRUG SAFETY

Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations

(2012) Robert H. Dworkin et al.   PAIN

Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.

(2011) C. A. Abbott et al.   DIABETES CARE

Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial

(2011) Jo Satoh et al.   Journal of Diabetes Investigation

A Longitudinal Assessment of Painful Diabetic Peripheral Neuropathy on Health Status, Productivity, and Health Care Utilization and Cost

(2010) Marco daCosta DiBonaventura et al.   PAIN MEDICINE

Translating the A1C Assay Into Estimated Average Glucose Values

(2008) D. M. Nathan et al.   DIABETES CARE

A graphical approach to sequentially rejective multiple test procedures

(2008) Frank Bretz et al.   STATISTICS IN MEDICINE